AveXis Reports Third Quarter 2016 Financial and Operating Results

Go back to AveXis Reports Third Quarter 2016 Financial and Operating Results

UPDATE: Stifel Starts AveXis (AVXS) at Hold

November 14, 2016 7:33 AM EST

(Updated - November 14, 2016 9:08 AM EST)

Stifel initiated coverage on AveXis (NASDAQ: AVXS) with a Hold rating and a price target of $65.

Analyst Katherine Breedis said, "We believe AVXS has strong management as well as an exciting gene therapy asset, Ph.I AVXS-101, which has... More

AveXis (AVXS) Reports Q3 Loss of $0.87/Share

November 10, 2016 4:05 PM EST

AveXis (NASDAQ: AVXS) reported Q3 EPS of ($0.87), versus ($0.67) reported last year.

For earnings history and earnings-related data on AveXis (AVXS) click here.

... More